Maze Therapeutics (MAZE) Shares Outstanding (2024 - 2026)

Maze Therapeutics' Shares Outstanding history runs 3 years deep, the most recent figure standing at $49.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 13.56% year-over-year to $49.7 million; the TTM figure through Mar 2026 stood at $49.7 million (up 13.56% YoY), while the FY2025 annual figure was $49.3 million, up 1916.28% from the prior year.
• Shares Outstanding came in at $49.7 million for Q1 2026 at Maze Therapeutics, up from $49.3 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $49.7 million in Q1 2026 to a low of $2.4 million in Q1 2024.
• A 3-year average of $27.2 million and a median of $43.8 million in 2025 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding surged 1916.28% in 2025 and gained 13.56% in 2026, its largest moves.
• Maze Therapeutics' Shares Outstanding stood at $2.4 million in 2024, then soared by 1916.28% to $49.3 million in 2025, then climbed by 0.81% to $49.7 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $49.7 million, $49.3 million, and $48.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison